Medical research

An experimental peptide could block COVID-19

In hopes of developing a possible treatment for COVID-19, a team of MIT chemists has designed a drug candidate that they believe may block coronaviruses' ability to enter human cells. The potential drug is a short protein ...

Alzheimer's disease & dementia

Scientists find a method of protection against Alzheimer's disease

A joint study on the Lynx1 protein has revealed that the protein competes with human nicotinic acetylcholine receptors for binding to amyloids, which are the main cause of Alzheimer's development. In the future, the protein ...

Medical research

How a protein meal tells your brain you are full

Feeling full involves more than just the uncomfortable sensation that your waistband is getting tight. Investigators reporting online on July 5th in the Cell Press journal Cell have now mapped out the signals that travel ...

Cardiology

Synthetic 'mini' receptors block atherosclerosis

Atherosclerosis, a lipid-triggered chronic inflammatory disease of the arteries, is the main cause of strokes and heart attacks. An international team of researchers led by the Technical University of Munich (TUM) and the ...

Oncology & Cancer

New therapy for childhood neuroblastoma proves feasible and safe

A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission ...

Neuroscience

Research shows binge drinking inhibits brain development

(Medical Xpress)—Teenagers who binge drink risk inhibiting part of their brain's development and many are laying the groundwork for alcoholism down the track a Queensland University of Technology (QUT) researcher has found.

Medications

Opioids produce analgesia via immune cells

Opioids are the most powerful painkillers. Researchers at the Charité - Universitätsmedizin Berlin have now found that the analgesic effects of opioids are not exclusively mediated by opioid receptors in the brain, but ...

Oncology & Cancer

Benefits of radionuclide therapy for neuroendocrine tumors

According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only in ...

page 1 from 4